Daniel Burke Email & Phone Number

I represent injured plaintiffs in matters including accidents/general negligence, medical malpractice, products liability, wrongful death, asbestos exposure, and consumer class actions. I primarily focus on pharmaceutical and medical device mass tort litigation, and I have extensive leadership experience as follows:• Appointed by the Hon. Karen K. Caldwell, U.S.D.J, to serve as a member of the Plaintiffs’ Executive Committee in In re: Onglyza (Saxagliptin) and Kombiglyze (Saxagliptin and Metformin) Products Liability Litigation (MDL 2809)• Appointed by the Hon. Robert L. Miller, Jr., U.S.D.J. to serve as a Member of the Plaintiffs' Steering Committee in In re: Biomet M2a Magnum Hip Implant Products Liability Litigation (MDL 2391);• Appointed by the Hon. Marcy Friedman, J.S.C to serve as Liaison Counsel in the New York Coordinated Plavix-Related Proceedings (Index No. 560001/12); • Appointed by the Hon. Rebecca Pallmeyer, U.S.D.J. to serve as a Member of the Plaintiffs' Steering Committee in In re: Zimmer Nexgen Knee Implant Products Liability Litigation (MDL 2272);• Served as a Member of the Discovery and Law & Briefing Sub-Committees for In re: Denture Cream Products Liability Litigation (MDL. 2051);• Served as a Member of the Science and Discovery Sub-Committees for Yasmin & Yaz (Drospirenone) Marketing, Sales Practices & Products Liability Litigation (MDL 2100).

Listed skills include Product Liability, Class Actions, Litigation, Torts, and 40 others.